Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial

Blinded outcome assessment in trials with prospective randomized open blinded end point design is challenging. Unblinding can result in misclassified outcomes and biased treatment effect estimates. An outcome adjudication committee assures blinded outcome assessment, but the added value for trials w...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Ende, Nadinda A.M., Roozenbeek, Bob, Berkhemer, Olvert A., Koudstaal, Peter J., Boiten, Jelis, van Dijk, Ewoud J., Roos, Yvo B.W.E.M., van Oostenbrugge, Robert J., Majoie, Charles B.L.M., van Zwam, Wim, Lingsma, Hester F., van der Lugt, Aad, Dippel, Diederik W.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700318/
https://www.ncbi.nlm.nih.gov/pubmed/34607469
http://dx.doi.org/10.1161/STROKEAHA.121.035301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700318/
https://www.ncbi.nlm.nih.gov/pubmed/34607469
http://dx.doi.org/10.1161/STROKEAHA.121.035301

Ejemplares similares